Page 3 - Thomas Ybert News Today

Veteran Life Science Executive and New Board Members Bring Deep Expertise to Advance the Company's Enzymatic DNA Synthesis (EDS) Technology and Commercialize its SYNTAX Platform DNA Script, a leader

DNA Script Advances Evaluation Program for the SYNTAX System, the First Benchtop DNA Printer Powered By Enzymatic Synthesis USA - English Share this article Share this article The SYNTAX System Delivers DNA On Demand to Enable Labs to Control Their Workflow, Innovate Faster SOUTH SAN FRANCISCO, Calif., and PARIS, May 20, 2021 /PRNewswire/ -- DNA Script, a leading pioneer in enabling enzymatic DNA synthesis on demand, today announced the third and final phase of its evaluation program for the ...

DNA Script will receive up to $9.35 million to leverage the company's novel enzymatic DNA synthesis (EDS) technology for the project This is the second announced project[1] where DNA Script

DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand PARIS and SOUTH SAN FRANCISCO, Calif., February 23, 2021 DNA Script, SAS, a leading pioneer in enabling DNA synthesis on demand, and baseclick GmbH announced today an exclusive licensing agreement that grants DNA Script use of the novel "Click" chemistry commercialized by baseclick. In effect, this agreement enables DNA Scripts customers to enzymatically synthesize high purity nuclei...

Company will receive $1.6 Million to develop a qPCR probe manufacturing platform to enable the fast detection of highly pathogenic viruses and bacteria DNA Script, a leading pioneer in enabling DNA